Catherine Sekerke

861 total citations
19 papers, 645 citations indexed

About

Catherine Sekerke is a scholar working on Surgery, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Catherine Sekerke has authored 19 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 12 papers in Molecular Biology and 6 papers in Computational Theory and Mathematics. Recurrent topics in Catherine Sekerke's work include Lipoproteins and Cardiovascular Health (11 papers), Computational Drug Discovery Methods (6 papers) and Plant biochemistry and biosynthesis (6 papers). Catherine Sekerke is often cited by papers focused on Lipoproteins and Cardiovascular Health (11 papers), Computational Drug Discovery Methods (6 papers) and Plant biochemistry and biosynthesis (6 papers). Catherine Sekerke collaborates with scholars based in United States and China. Catherine Sekerke's co-authors include Peter O. Kwiterovich, Roger S. Newton, Bruce D. Roth, Drago R. Sliskovic, Erika Ferguson, Sharmistha Chatterjee, C. John Blankley, Bruce J. Auerbach, M. L. HOEFLE and Michael Wilson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Catherine Sekerke

19 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Catherine Sekerke United States	16	278	222	201	102	70	19	645
Erika Ferguson United States	13	295 1.1×	144 0.6×	206 1.0×	103 1.0×	78 1.1×	16	747
Henrietta Dehmlow Switzerland	15	621 2.2×	197 0.9×	183 0.9×	84 0.8×	122 1.7×	21	969
David R. Magnin United States	14	332 1.2×	367 1.7×	81 0.4×	69 0.7×	85 1.2×	21	736
M. L. HOEFLE United States	11	259 0.9×	304 1.4×	73 0.4×	71 0.7×	73 1.0×	18	613
Carsten Schmeck Germany	15	309 1.1×	312 1.4×	69 0.3×	154 1.5×	71 1.0×	26	759
Richard L. Stanfield United States	16	315 1.1×	177 0.8×	359 1.8×	45 0.4×	41 0.6×	38	682
Colin J. Theobald United Kingdom	13	243 0.9×	142 0.6×	107 0.5×	17 0.2×	32 0.5×	18	464
Steven A. Boyd United States	18	322 1.2×	320 1.4×	49 0.2×	40 0.4×	63 0.9×	34	739
Hiroyuki Kakinuma Japan	14	325 1.2×	288 1.3×	73 0.4×	83 0.8×	45 0.6×	43	744
Michel Souchet France	13	227 0.8×	186 0.8×	48 0.2×	99 1.0×	48 0.7×	22	514

Countries citing papers authored by Catherine Sekerke

Since Specialization

Citations

This map shows the geographic impact of Catherine Sekerke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Sekerke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Sekerke more than expected).

Fields of papers citing papers by Catherine Sekerke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Sekerke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Sekerke. The network helps show where Catherine Sekerke may publish in the future.

Co-authorship network of co-authors of Catherine Sekerke

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Sekerke. A scholar is included among the top collaborators of Catherine Sekerke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Sekerke. Catherine Sekerke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Park, William K.C., Robert M. Kennedy, Scott D. Larsen, et al.. (2007). Hepatoselectivity of statins: Design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(3). 1151–1156. 45 indexed citations

Auerbach, Bruce J., Chulho Choi, Jeffrey C. Hanselman, et al.. (2007). Discovery of pyrrole-based hepatoselective ligands as potent inhibitors of HMG-CoA reductase. Bioorganic & Medicinal Chemistry. 15(16). 5576–5589. 25 indexed citations

Pfefferkorn, Jeffrey A., Chulho Choi, Yuntao Song, et al.. (2007). Design and synthesis of novel, conformationally restricted HMG-CoA reductase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(16). 4531–4537. 30 indexed citations

Larsen, Scott D., Kevin J. Filipski, Jeffrey T. Kohrt, et al.. (2007). Pyrazole inhibitors of HMG-CoA reductase: An attempt to dramatically reduce synthetic complexity through minimal analog re-design. Bioorganic & Medicinal Chemistry Letters. 17(20). 5567–5572. 11 indexed citations

Pfefferkorn, Jeffrey A., Chulho Choi, Scott D. Larsen, et al.. (2007). Substituted Pyrazoles as Hepatoselective HMG-CoA Reductase Inhibitors: Discovery of (3R,5R)-7-[2-(4-Fluoro-phenyl)-4-isopropyl-5-(4-methyl-benzylcarbamoyl)-2H-pyrazol-3-yl]-3,5-dihydroxyheptanoic Acid (PF-3052334) as a Candidate for the Treatment of Hypercholesterolemia. Journal of Medicinal Chemistry. 51(1). 31–45. 44 indexed citations

Spahr, Mark A., et al.. (1998). CI-1011 lowers lipoprotein(a) and plasma cholesterol concentrations in chow-fed cynomolgus monkeys. Atherosclerosis. 136(1). 79–87. 24 indexed citations

Walter, Gary A., et al.. (1998). Development, Validation, and Interlaboratory Comparison of an HMG-CoA Reductase Inhibition Assay for Quantitation of Atorvastatin in Plasma Matrices. Therapeutic Drug Monitoring. 20(1). 41–49. 18 indexed citations

Bisgaier, C L, Arnold D. Essenburg, Bruce J. Auerbach, et al.. (1997). Attenuation of plasma low density lipoprotein cholesterol by select 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in mice devoid of low density lipoprotein receptors. Journal of Lipid Research. 38(12). 2502–2515. 66 indexed citations

Spahr, Mark A., et al.. (1997). Retinoids Inhibit Primary Cynomolgus Monkey Hepatocyte Lipoprotein(a) Levels. Biochemical and Biophysical Research Communications. 238(1). 48–52. 4 indexed citations

10.

Spahr, Mark A., et al.. (1996). Expression of apolipoprotein[a] and plasminogen mRNAs in cynomolgus monkey liver and extrahepatic tissues. Journal of Lipid Research. 37(9). 2029–2040. 24 indexed citations

11.

Krause, Brian R., Audrey S. Black, Richard F. Bousley, et al.. (1993). Divergent pharmacologic activities of PD 132301-2 and CL 277,082, urea inhibitors of acyl-CoA:cholesterol acyltransferase.. Journal of Pharmacology and Experimental Therapeutics. 267(2). 734–743. 28 indexed citations

12.

Sliskovic, Drago R., C. John Blankley, Brian R. Krause, et al.. (1992). Inhibitors of cholesterol biosynthesis. 6. trans-6-[2-(2-N-heteroaryl-3,5-disubstituted-pyrazol-4-yl)ethyl/ethenyl]tetrahydro-4-hydroxy-2H-pyran-2-ones. Journal of Medicinal Chemistry. 35(11). 2095–2103. 16 indexed citations

13.

Roth, Bruce D., C. John Blankley, Alexander Chucholowski, et al.. (1991). Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran 2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleus. Journal of Medicinal Chemistry. 34(1). 357–366. 151 indexed citations

14.

Sliskovic, Drago R., W. Howard Roark, Bruce D. Roth, et al.. (1991). Inhibitors of cholesterol biosynthesis. 4. trans-6-[2-(Substituted-quinolinyl)ethenyl/ethyl]tetrahydro-4-hydroxy-2H-pyran-2-ones, a novel series of HMG-CoA reductase inhibitors. Journal of Medicinal Chemistry. 34(1). 367–373. 44 indexed citations

15.

Roth, Bruce D., C. John Blankley, Alexander Chucholowski, et al.. (1991). ChemInform Abstract: Inhibitors of Cholesterol Biosynthesis. Part 3. Tetrahydro‐4‐hydroxy‐6‐ (2‐(1H‐pyrrol‐1‐yl)ethyl)‐2H‐pyran‐2‐one Inhibitors of HMG‐CoA Reductase. Part 2. Effects of Introducing Substituents at Positions Three and Four of the Pyrrole Nucleus.. ChemInform. 22(24). 1 indexed citations

16.

Chatterjee, Snehajyoti, Catherine Sekerke, & Peter O. Kwiterovich. (1982). Increased urinary excretion of glycosphingolipids in familial hypercholesterolemia.. Journal of Lipid Research. 23(4). 513–522. 24 indexed citations

17.

Chatterjee, Subroto, Catherine Sekerke, & Peter O. Kwiterovich. (1981). Effects of Tunicamycin on the Cell‐Surface Binding, Internalization and Degradation of Low‐Density Lipoproteins in Human Fibroblasts. European Journal of Biochemistry. 120(3). 435–441. 35 indexed citations

18.

Chatterjee, Sharmistha, Peter O. Kwiterovich, & Catherine Sekerke. (1979). Effects of tunicamycin on the binding and degradation of low density lipoproteins and glycoprotein synthesis in cultured human fibroblasts.. Journal of Biological Chemistry. 254(10). 3704–3707. 33 indexed citations

19.

Chatterjee, Sharmistha, Catherine Sekerke, & Peter O. Kwiterovich. (1976). Alterations in cell surface glycosphingolipids and other lipid classes of fibroblasts in familial hypercholesterolemia.. Proceedings of the National Academy of Sciences. 73(12). 4339–4343. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact